Article
[Clinical significance of the determination of oxidation and acetylation phenotype in patients with multiple sclerosis].
Neurologia i neurochirurgia polska - 1 Jan 2000
Milejski P, Orzechowska-Juzwenko K, Pawlik J, Kamienowski J, Horoch E, Niewiński P, Hurkacz M
Abstract excerpt
Genetically determined individual differences in the ability of oxidation and acetylation of certain drugs have raised in recent years a considerable interest in view of their clinical importance. The purpose of the study was finding out of a possible difference in the ability to oxidized sparteine and to acetylate sulfamidine as model drugs between patients with multiple sclerosis and healthy control volunteers....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
